Sodium–glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study
- DOI
- 10.1097/meg.0000000000003264
- Published
- 2026-08-11
- Container
- European Journal of Gastroenterology & Hepatology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/meg.0000000000003264,
title = {Sodium–glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study},
author = {Elias Helal and Elona Shehi and Ahmad Al Homaid and Migena Dervishi and Devendra K. Tripathi},
year = {2026},
journal = {European Journal of Gastroenterology \& Hepatology},
doi = {10.1097/meg.0000000000003264},
url = {https://doi.org/10.1097/meg.0000000000003264}
}RIS
TY - JOUR TI - Sodium–glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study AU - Elias Helal AU - Elona Shehi AU - Ahmad Al Homaid AU - Migena Dervishi AU - Devendra K. Tripathi PY - 2026 JO - European Journal of Gastroenterology & Hepatology DO - 10.1097/meg.0000000000003264 UR - https://doi.org/10.1097/meg.0000000000003264 ER -
APA
Helal, E., Shehi, E., Homaid, A. A., Dervishi, M., & Tripathi, D. K. (2026). Sodium–glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000003264
Source records
- crossref · retrieved 2026-09-26T06:40:56.023Z